Value Chain Analysis of Glaxo Smith Kline Prepared By: Abu Jubaer

1. Value Chain
Analysis of

2. Company Overview
• One of the world's leading research-based pharmaceutical and
healthcare companies
• Committed to improving the quality of human life by enabling
people to do more, feel better and live longer.
• GSK has fast growth rate and Bangladesh is among top leading
pharmaceutical industries

3. Profiles Analysis
Company Profile GLAXOSMITHKLINE
Established 1924
Turnover 26.4 billion
Employee 100000
Product Range Anti-infective, dermatology, gynecology, diabetes,
oncology, cardiovascular disease and respiratory
diseases. vaccines, for hepatitisA, hepatitis B,
invasive disease caused by H, influenza, chickenpox,
diphtheria, pertussis, tetanus, rotavirus, cervical
cancer, streptococcus pneumonia and others.

4. Comparison of vision, mission and competitive
advantage
Organization Vision Mission COMPETITIVE
ADVANTAGE
.
GLAXOSMITHKLINE
We want to become the
indisputable leader in our
industry - not simply in
terms of size, but in how
we use that size to achieve
our mission and improve
the quality of human life.
Becoming the
indisputable leader in our
industry means
conquering the challenges
that face us as an industry,
and as a global society
our mission is to improve
the quality of life by
enabling people to do
more, feel better and live
longer.This mission drives
us to make a real
difference to the lives of
millions of people with our
commitment to effective
healthcare solutions.
Strong R&D focus and
exploring new markets

5. Value chain analysis: Primary Activities
OPERATION
• Operation include manufacture, formulate, fill, pack, control, release and deliver over 1.4 billion doses.
• OperationalSustainabilityTeam help for this purpose
SALES AND
MARKETING
• Commercial teams are responsible for understanding our patients, consumers and customers.
SERVICES
• GlaxoSmithKline consumer healthcare Bangladesh

6. Value Chain Analysis: Secondary Activities
FIRM
INFRASTRUCTURE
• corporate office
• Manufacturing
Units
• R& D department
HUMAN RESOURCE
MANAGEMENT
• Compensation,
• Organizational
Development,
• Learning and
Development
RESEARCH AND
DEVELOPMENT
• Bioelectronics
• Tackling, the
threats of
antibiotic
resistance, and
• Epigenetic-turn-
ons and turn-offs

7. Conclusion
• After strategic analysis of GlaxoSmithKline pharmaceutical it can
be straight way concluded that their strategies are aligned with
their vision and mission; GlaxoSmithKline investing huge money in
R&D and exploring new market to become indisputable leader of
industry.These comparative strategic analyses of gsk
pharmaceutical provide the concise analysis of the company.